The Asia Pacific Mammography Systems Market would witness Market growth of 8.9% CAGR during the forecast period (2022-2028).
The Market is predicted to rise due to a rise in the geriatric population, increasing attempts by healthcare institutions to spread awareness about the early detection of breast cancer, and a rise in the incidence rate of breast cancer.
In addition, improved insurance reimbursement policies, more government funding for breast cancer research, & technological advancements like breast tomosynthesis, which aids in the early detection of breast cancer in women with all of these factors contribute to a rise in the demand for mammography systems.
Some of the key factors expected to boost demand for breast cancer diagnostic equipment throughout the forecast period include the rising prevalence of breast cancer. Moreover, increased availability of breast cancer screening systems and expanding government initiatives to promote clinical interpretation would support the overall development of the Market . The Health Resources and Services Administration (HRSA), for example, had launched a healthcare initiative to enhance screening procedures in medically underserved areas.
The increased prevalence of breast cancer, large R&D expenditure in breast cancer medicines, and innovations in breast imaging modalities are all contributing to the Asia-Pacific mammography Market 's growth. Breast cancer is the most frequent malignancy in most Asian countries. Because of lifestyle & nutritional changes, incidence rates are increasing at a higher rate than in West-Asian countries.
As per the Centers for Disease Control and Prevention, breast cancer is one of the most common cancers among Asian women. The rising prevalence of breast cancer & the region's expanding healthcare infrastructure are projected to drive overall growth. The predicted age-standardized incidence rate of breast cancer in Asia is 34.4 per 100,000, according to GLOBOCAN 2018. Moreover, according to the National Library of Medicines, the prevalence of breast cancer is also high in China. In the nation, 1.6 million people are being diagnosed with breast cancer, out of which, 1.2 million people die annually. Furthermore, the significant rise in population is another element that is encouraging the growth of the mammography Market .
The China Market dominated the Asia Pacific Mammography Systems Market by Country in 2021, and would continue to be a dominant Market till 2028; thereby, achieving a Market value of $317.5 million by 2028. The Japan Market is anticipated to grow at a CAGR of 8.3% during (2022 - 2028). Additionally, The India Market would witness a CAGR of 9.7% during (2022 - 2028).
Based on Product Type, the Market is segmented into Analog and Digital. Based on Modality, the Market is segmented into Portable and Non-Portable. Based on End User, the Market is segmented into In-patient Settings and Ambulatory Surgical Centers. Based on countries, the Market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Mammography Systems Market is Projected to reach USD 3.6 Billion by 2028, at a CAGR of 7.2%
The Market research report covers the analysis of key stake holders of the Market . Key companies profiled in the report include Siemens AG, Fujifilm Holdings Corporation, Canon, Inc., General Electric (GE) Co., Hologic, Inc., Koninklijke Philips N.V., Metaltronica S.p.A., Allengers Medical Systems Ltd., Planmed Oy, and Konica Minolta, Inc.
By Product Type
By Modality
By End User
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
